Patrick Sullivan (Insider Trades), CEO and Chairman of the Board of Insulet Corp. (PODD), acquired 40,000 shares of the company on December 2, 2016. The average per share price was $33.89, for a total transaction of $1,355,600. Insulet Corp. is a medical device company focused on diabetes management. The company seeks to help patients with insulin-dependent diabetes with its Omnipod Insulin Management System. Insulet Corp. has a market cap of 2.02 billion.
The volume of insider buys increased, while the number of insider sells decreased each year since 2013. There were 20 insider sell totaling 508,766 shares in 2013, and 7 insider sells totaling 39,997 shares in 2015. In comparison, there were no insider buys of PODD during 2013, while insiders purchased 49,014 shares of the company in 7 transactions in 2015. To date since 2015, Sullivan purchased 115,000 shares of the company. Sullivan’s earliest transaction with PODD of 10,000 shares at an average per share price of $31.93, increased in price by about 3% since the purchase in March 2015. Another PODD insider, Executive Vice President Bradley Thomas (Insider Trades), purchased 3,100 shares of the company for an average per share price of $32.45 on December 1, 2016. For more information about insider trades with PODD, click here. Continue Reading »